Fox Health

The United States is devoting $3.2 billion to advance development of antiviral pills for COVID-19 and other dangerous viruses that could turn into pandemics.

The U.K.'s latest surge in coronavirus infections gathered pace Thursday with new confirmed cases rising above 10,000 for the first time in nearly four months as a result of the spread of the more contagious delta variant.

A top official with Europe’s regulatory agency on Thursday said it would weigh COVID-19 vaccines for approval despite the efficacy potentially falling below a 50% threshold.

Novartis announced on Wednesday that the FDA granted Breakthrough Therapy designation to an experimental therapy that targets advanced castration-resistant prostate cancer.

While a preferred method of many dieters, intermittent fasting may not be the most effective way to lose weight.

Preliminary data behind German biopharmaceutical company CureVac's COVID-19 vaccine candidate revealed a disappointing 47% efficacy against COVID-19 disease of any severity, and failed to meet statistical success criteria in a late-stage trial, sending stocks tanking.

Australia has limited use of the AstraZeneca vaccine to those 60 and over, recommending that younger adults receive the Pfizer-BioNTech jab instead amid instances of rare, severe blood clots.

Indonesia’s president ordered authorities to speed up the country's vaccination campaign as the World Health Organization warned Thursday of the need to increase social restrictions in the country amid a fresh surge of coronavirus infections caused by worrisome variants.

As cases tumble and states reopen, the potential final stage in the U.S. campaign to vanquish COVID-19 is turning into a slog, with a worrisome variant gaining a bigger foothold and lotteries and other prizes failing to persuade some Americans to get vaccinated.

Can you mix and match two-dose COVID-19 vaccines?

A Rhode Island man became the first patient worldwide to receive Biogen’s hotly debated Alzheimer’s drug outside of a clinical trial on Wednesday, a hospital spokesperson confirmed to Fox News.

A large study found nearly one quarter of coronavirus survivors received first-time diagnoses for other medical ailments following 30 days of infection.

The Food and Drug Administration on Tuesday announced that it had authorized an additional batch of Johnson & Johnson COVID-19 vaccine that had been produced from a troubled Baltimore facility.

Health officials in Connecticut announced the state’s first two cases of Powassan virus detected in 2021.

Regeneron’s COVID-19 therapy was found to reduce the risk of death in hospitalized patients who had not mounted their own immune response to the virus by up to 20%, the company said Wednesday

An Arizona family is mourning the death of their 24-year-old daughter who they claim sought weight loss surgery in Mexico and later died in a hospital in her home state due to complications from the procedure.

Reports of heart inflammation among a small fraction of Pfizer and Moderna COVID-19 vaccine recipients, predominantly males under 30, are under review as an advisory panel to the Centers for Disease Control and Prevention is set to meet Friday.

A new treatment triggered immune cells to clear out toxic plaque buildup and slow progression of Alzheimer’s disease in monkeys, researchers claim.

New York Gov. Andrew Cuomo announced Tuesday that all remaining COVID-19 restrictions "would be relaxed as of today" after the state reached its goal of vaccinating 70% of the adult population, but mask-wearing would remain in effect for some.

The U.S. recorded a grim milestone Tuesday with over 600,000 deaths attributed to coronavirus, according to data from Johns Hopkins University. However, the news comes as weekly fatalities have declined to lows not seen since early on in the pandemic.